Prognia
Drug Database
🇪🇺EU · EMAApplication withdrawnOrphan Medicine

Blectifor(Caffeine citrate)

Bronchopulmonary Dysplasia

Marketing Authorisation Holder: Viridian Pharma Ltd

INN: caffeine citrate

Indication

Indicated in preterm neonates for the prevention of bronchopulmonary dysplasia

Official EMA Resources

View on EMA (ema.europa.eu)

AI Drug & Interaction Analysis

Free account required

Ask Prognia AI about Blectifor — dosing recommendations, drug interactions, and current guideline evidence from ESC, EMA, NICE and more.

Medical disclaimer: This information is intended for qualified healthcare professionals. Always verify with the official EMA Summary of Product Characteristics (SmPC) before clinical use.